LW402

History

Earliest recorded event: May 11, 2023. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

• Mar 3, 2026Phase 3 trial startedEvaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis ClinicalTrials.gov NCT07370909
• Feb 13, 2025Phase 2 trial completedStudy of LW402 in Moderate-to-Severe Atopic Dermatitis ClinicalTrials.gov NCT07186387
• Sep 25, 2024Phase 2 main data collectedStudy of LW402 in Moderate-to-Severe Atopic Dermatitis ClinicalTrials.gov NCT07186387
• May 11, 2023Phase 2 trial startedStudy of LW402 in Moderate-to-Severe Atopic Dermatitis ClinicalTrials.gov NCT07186387

Sources

Trials

• NCT07186387
• NCT07370909